Cheng Liu insider trades

Open-market stock purchases and sales by Cheng Liu, CEO at Estrella Immunopharma, Inc, from SEC Form 4 filings since Oct 30, 2024.

Recent trades

DateStockTradeValue
Aug 25, 2026ESLA Estrella Immunopharma, IncBought (not open market)—

Companies traded

  • ESLA Estrella Immunopharma, Inc: other filings, last Aug 25, 2026

Get free alerts when Cheng Liu files a new trade →